Aurinia Pharmaceuticals AUPH
$14.70 −$0.19 (-1.28%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $14.64 -0.41%
Open$14.69
Prev close$14.89
Day range$14.63 – $14.97
Volume1.34M
Market cap$1.97B
P/E (TTM)6.4
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$83.70M+13.9% YoY
Operating profit$35.36M+18.9% YoY
Net profit$31.70M+0.5% YoY
Diluted EPS$0.23+0.0% YoY
Free cash flow$46.34M+4.4% YoY
Operating cash flow$46.37M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin90.6%
Operating margin48.6%
Net margin97.7%
Return on equity61.4%
Return on assets46.4%
Return on invested capital53.1%
Current ratio6.12
Liabilities / assets20.4%
Cash & investments$486.88M
Total debt$40.71M
Net cash (debt)$446.18M
Free cash flow / sales55.0%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $83.70M | $83.22M | $77.71M | $283.06M | $77.11M |
| Total Operating Revenue | $83.70M | $83.22M | $77.71M | $283.06M | $77.11M |
| Cost of Revenue | $8.31M | $6.56M | $6.51M | $32.67M | $8.80M |
| Gross Profit | $75.39M | $76.67M | $71.20M | $250.39M | $68.32M |
| Operating Expense | $40.03M | $30.32M | $29.78M | $143.83M | $35.08M |
| Selling and Admin Expenses | $24.68M | $23.51M | $22.03M | $101.79M | $29.26M |
| -Selling & Marketing Expense | $787,000.00 | $535,000.00 | $327,000.00 | $3.21M | $785,000.00 |
| -General & Admin Expense | $23.90M | $22.97M | $21.70M | $98.59M | $28.47M |
| Research & Development | $16.61M | $13.05M | $7.47M | $32.51M | $10.90M |
| Other Operating Expenses | -$1.27M | -$6.23M | $279,000.00 | $9.53M | -$5.07M |
| Operating Profit | $35.36M | $46.34M | $41.42M | $106.56M | $33.24M |
| Net Non-Operating Interest Income (Expense) | $3.35M | $2.45M | $2.50M | $9.24M | $2.45M |
| Non-Operating Interest Income | $4.22M | $3.39M | $3.52M | $13.57M | $3.50M |
| Non-Operating Interest Expense | $867,000.00 | $948,000.00 | $1.01M | $4.33M | $1.05M |
| Special Income (Charges) | $0.00 | $0.00 | $0.00 | -$1.65M | $0.00 |
| -Less:Restructuring and Mergern & Acquisition | $0.00 | $0.00 | $0.00 | $1.65M | $0.00 |
| Pretax Profit | $38.72M | $48.79M | $43.93M | $114.16M | $35.69M |
| Tax | $7.01M | $11.37M | $9.57M | -$173.05M | -$175.10M |
| Net Profit | $31.70M | $37.41M | $34.36M | $287.20M | $210.79M |
| Profit from Continuing Operations | $31.70M | $37.41M | $34.36M | $287.20M | $210.79M |
| Net Income to Parent Company | $31.70M | $37.41M | $34.36M | $287.20M | $210.79M |
| Net Income to Common Stockholders | $31.70M | $37.41M | $34.36M | $287.20M | $210.79M |
| Basic EPS | $0.24 | $0.29 | $0.26 | $2.14 | $1.60 |
| Diluted EPS | $0.23 | $0.28 | $0.25 | $2.07 | $1.53 |
| Other Income (Expense) | – | – | – | -$1.65M | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $825.70M | $792.26M | $724.00M | $751.59M | $751.59M |
| Total Current Assets | $587.89M | $541.32M | $480.24M | $491.97M | $491.97M |
| Cash and Cash Equivalents & Short-Term Investments | $486.88M | $443.12M | $378.78M | $398.00M | $398.00M |
| -Cash and Cash Equivalents | $46.15M | $179.83M | $41.01M | $80.21M | $80.21M |
| -Short Term Investments | $440.74M | $263.29M | $337.78M | $317.78M | $317.78M |
| Receivables | $47.41M | $41.14M | $49.18M | $41.45M | $41.45M |
| -Accounts Receivable | $47.41M | $41.14M | $49.18M | $41.45M | $41.45M |
| Prepaid Assets | $5.92M | $10.53M | $4.12M | $5.75M | $5.75M |
| Inventory | $43.73M | $45.15M | $46.41M | $45.69M | $45.69M |
| Other Current Assets | $3.95M | $1.38M | $1.76M | $1.08M | $1.08M |
| Total Non-Current Assets | $237.82M | $250.94M | $243.75M | $259.62M | $259.62M |
| Net PPE | $63.90M | $68.53M | $73.15M | $79.57M | $79.57M |
| -Gross PPE | $67.43M | $71.93M | $76.43M | $82.73M | $82.73M |
| -Accumulated Depreciation | -$3.53M | -$3.40M | -$3.28M | -$3.15M | -$3.15M |
| Goodwill and Other Intangible Assets | $3.17M | $3.38M | $3.59M | $3.76M | $3.76M |
| -Other Intangible Assets | $3.17M | $3.38M | $3.59M | $3.76M | $3.76M |
| Non-Current Deferred Assets | $170.65M | $178.94M | $166.92M | $176.19M | $176.19M |
| Other Non-Current Assets | $93,000.00 | $93,000.00 | $93,000.00 | $93,000.00 | $93,000.00 |
| Total Liabilities | $168.19M | $177.40M | $156.37M | $170.26M | $170.26M |
| Total Current Liabilities | $96.01M | $99.89M | $86.56M | $93.72M | $93.72M |
| Payables | $4.05M | $2.60M | $4.20M | $5.32M | $5.32M |
| -Accounts Payable | $3.01M | $1.74M | $2.66M | $3.31M | $3.31M |
| -Total Tax Payable | $1.03M | $860,000.00 | $1.54M | $2.01M | $2.01M |
| Current Accrued Expenses | $62.27M | $63.25M | $56.65M | $64.61M | $64.61M |
| Short-Term Debt and Capital Lease Obligation | $17.96M | $18.18M | $18.14M | $17.59M | $17.59M |
| -Current Capital Lease Obligation | $17.96M | $18.18M | $18.14M | $17.59M | $17.59M |
| Current Deferred Liabilities | $10.41M | $10.59M | $5.04M | $3.72M | $3.72M |
| Other Current Liabilities | $1.32M | $5.27M | $2.52M | $2.48M | $2.48M |
| Total Non-Current Liabilities | $72.18M | $77.51M | $69.82M | $76.53M | $76.53M |
| Long Term Debt and Capital Lease Obligation | $40.71M | $45.95M | $50.50M | $57.22M | $57.22M |
| -Long Term Capital Lease Obligation | $40.71M | $45.95M | $50.50M | $57.22M | $57.22M |
| Non-Current Deferred Liabilities | $30.29M | $30.61M | $12.41M | $12.65M | $12.65M |
| Other Non-Current Liabilities | $1.19M | $945,000.00 | $6.90M | $6.66M | $6.66M |
| Total Equity | $657.52M | $614.86M | $567.63M | $581.33M | $581.33M |
| Stockholders' Equity | $657.52M | $614.86M | $567.63M | $581.33M | $581.33M |
| Capital Stock | $1.13B | $1.12B | $1.09B | $1.12B | $1.12B |
| -Common Stock | $1.13B | $1.12B | $1.09B | $1.12B | $1.12B |
| Additional Paid-In Capital | $77.04M | $76.19M | $96.87M | $111.26M | $111.26M |
| Retained Earnings | -$545.90M | -$577.60M | -$615.01M | -$649.37M | -$649.37M |
| Gains/Losses Not Affecting Retained Earnings | -$1.13M | -$977,000.00 | -$880,000.00 | -$599,000.00 | -$599,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $46.37M | $52.57M | $32.56M | $135.66M | $45.67M |
| Net cash flow from continuing operations | $46.37M | $52.57M | $32.56M | $135.66M | $45.67M |
| Net Income from Continuing Operations | $31.70M | $37.41M | $34.36M | $287.20M | $210.79M |
| Gain/Loss from Continuing Operations | -$1.63M | -$561,000.00 | -$416,000.00 | $9.69M | $367,000.00 |
| Depreciation & Depletion & Amortization | $4.84M | $4.83M | $4.82M | $19.45M | $4.86M |
| Deferred Tax | $8.28M | $11.11M | $9.28M | -$176.19M | -$176.19M |
| Other Non-Cash Items | $584,000.00 | -$2.66M | $581,000.00 | -$200,000.00 | -$5.05M |
| Change in Working Capital | -$1.60M | $1.47M | -$12.87M | -$8.78M | $6.50M |
| -Change in Receivables | -$6.28M | $8.04M | -$7.72M | -$4.91M | -$10.73M |
| -Change in Inventory | $1.42M | $1.26M | -$720,000.00 | -$6.46M | -$897,000.00 |
| -Change in Prepaid Assets | $2.05M | -$5.98M | $950,000.00 | $5.52M | $4.58M |
| -Change in Payables and Accrued Expense | $1.94M | -$2.24M | -$6.24M | -$6.53M | $14.22M |
| -Change in Other Current Assets | $0.00 | – | – | $730,000.00 | $0.00 |
| -Change in Other Current Liabilities | -$229,000.00 | -$227,000.00 | -$214,000.00 | -$802,000.00 | -$202,000.00 |
| -Change In Other Working Capital | -$503,000.00 | $624,000.00 | $1.08M | $3.67M | -$482,000.00 |
| Net cash flow from investing | -$175.73M | $81.45M | -$18.08M | -$32.77M | -$36.76M |
| Net Cash Flow from Continuing Investing Activities | -$175.73M | $81.45M | -$18.08M | -$32.77M | -$36.76M |
| Net PPE Purchase and Sale | -$24,000.00 | $0.00 | -$39,000.00 | -$252,000.00 | -$72,000.00 |
| Net Business Purchase and Sale | $0.00 | – | – | – | – |
| Net Investment Purchase and Sale | -$175.71M | $76.24M | -$18.04M | -$32.52M | -$36.68M |
| Financing Cash Flow | -$4.32M | $4.81M | -$53.69M | -$106.11M | -$1.89M |
| Net Cash Flow from Continuing Financing Activities | -$4.32M | $4.81M | -$53.69M | -$106.11M | -$1.89M |
| Net Issuance Payments Of Debt | -$3.84M | -$3.41M | -$3.65M | -$13.14M | -$3.49M |
| Net Common Stock Issuance | $0.00 | -$38.72M | -$36.17M | -$98.16M | $0.00 |
| Proceeds from Stock Option Exercised | $10.41M | $58.80M | $713,000.00 | $14.95M | $1.96M |
| Net Other Financing Charges | -$10.88M | -$11.87M | -$14.58M | -$9.76M | -$364,000.00 |
| Ending Cash Balance | $46.15M | $179.83M | $41.01M | $80.21M | $80.21M |
| Net Change in Cash | -$133.69M | $138.82M | -$39.21M | -$3.22M | $7.02M |
| Beginning Cash Balance | $179.83M | $41.01M | $80.21M | $83.43M | $73.19M |
| Free Cash Flow | $46.34M | $52.57M | $32.52M | $135.41M | $45.60M |
No comments yet — be the first to weigh in on AUPH.
Sign in to join the discussion.